Bengaluru, March 01 , 2016: Dermozone, a global wound healing and Herbal Skincare Products Company, announced that it has developed ‘dalethyneTM ‘, a revolutionary chemical molecule compound, proven as an
antimicrobial agent against most of the bacteria, fungi and yeasts. Dermozone’s best kept secret, ‘dalethyneTM ‘will be the key ingredient in the company’s MedCare range of wound healing herbal products soon to be launched in India.
Dalethyne will be a life saver for thousands of patients especially those suffering from chronic skin ailments like Acne, Fungal Infections, Dry Skin, Insect Bites, Athlete’s Foot, Eczema, Blisters, Carbuncles and more importantly diabetic wounds, ulcers and burns.
Dermozone’s ‘MedCare’ brand comprises of four products- WOUNDCARE (wound and burn), VAGINYCARE (feminine usage), BABYCARE (allergies, rashes etc) and MEDCARE SOAP. Dermozone also has another brand- ‘BodyCare’ that caters to the cosmetics and beauty care market with a range of seventeen products.
MR. K.S. DHARSHAN, CHAIRMAN & CEO OF DERMOZONE, SAID “‘dalethyneTM ‘ is a unique compound created when olive oil is subjected to changes through a process called Ozonation for which I hold the IP right. This unique product is what ‘dalethyneTM ‘carries, with an increased efficacy stimulating the function of enzymes associated with your skin. This fastens the regeneration period of your skin when applied on cuts or wounds, also cures many skin infections in no time. ‘dalethyneTM ‘is no doubt our best kept secret in the complete range of Dermozone products”
Dermozone, with headquarters in Jakarta, Indonesia had recently announced its entry into the Indian market, by setting up an office in Bengaluru in the name of Indo- Dermozone Herbal Pvt. Ltd. Dermozone also has operations in UK, USA, Japan, Russia, Seoul, China, Taiwan, Hong Kong, South Africa, Brazil, Argentina, Mexico, Chile, Australia and Dubai (Middle East).
SAID MR. MANJUNATHA K.G ,CHIEF OPERATION OFFICER OF INDO- DERMOZONE HERBAL PVT. LTD ,”Dermozone has spent many years in researching and in perfecting a balanced and safe to use chemical design of ‘dalethyneTM ‘ .The company comprises of a team of highly qualified and competent people who have dedicated and spent a lifetime in making this innovative product. We are associated with many laboratories around the world which enables us to make sure that our ‘dalethyneTM ‘ would do its purpose and function in helping maintain much healthier skin. We have done numerous tests on biological and chemical functioning of the product and we have confirmed and proved both theoretically and experimentally with stringent testing that we have produced the best ‘dalethyneTM ‘”.
Currently, Dermozone’s MedCare product ‘WoundCare’ is under clinical trial at Apollo Hospitals, Chennai and expected to be completed by the second quarter of 2016.
Corporate Comm India (CCI Newswire)
